Tuesday, September 8, 2009
NIH Study Stopped Early Due to Safety Concerns
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has stopped a clinical trial testing a drug treatment for pulmonary hypertension in adults with sickle cell disease nearly one year early due to safety concerns. See full article here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment